Introduction
Material and methods
Pathological analysis
Primary antibody | Antibody type | Target | Source | Staining |
---|---|---|---|---|
PLP | Mouse (mAB) | Proteolipid protein | MCA8394; AbD Serotec | 1:1000; E |
MAG | Mouse (mAB) | Myelin-associated glycoprotein | ab89780; Abcam | 1:1000; E |
MOG | Mouse /mAB) | Myelin oligodendrocyte glycoprotein | 8-18C5; C. Lininton, Cardiff, UK | 1:1000; C |
GFAP | Mouse (mAB) | Glial fibrillary acid protein | 0410080; ThermoSc | 1:200; E |
pNF | Mouse (mAB) | Phosphorylated Neurofilament | Affinity, SMI31,NA1219, Exeter, UK | 1:20000; E |
APP | Mouse (mAB) | Amyloid precursor protein | MAB348; Chemicon, Temecula, CA, USA | 1:1000; C |
Iba1 | Rabbit (pAB) | Ionized calcium binding adaptor molecule 1 | 019-19741; WAKO Chemicals, Neuss, Germany | 1:3000; E |
CD68 | Mouse (mAB) | Cluster of Differentiation 68 | M0814; Dako | 1:100; E |
p22phox | Rabbit (pAB) | NADPH oxidase | Sc-20781; Santa Cruz, | 1:100; C |
CD3 | Rabbit (mAB) | T-cells | RM-9107-S; Neomarkers, Fremont, CA, USA | 1:2000; E |
CD4 | Mouse (mAB) | CD4 T-cells | ACRIS, 1F6; DM-119-05, San Diego, CA, USA | 1:1000; E |
CD8 | Mouse (mAB) | CD8 T-cells | M7103; Dako, Glostrup, Denmark | 1:250; E |
CD20 | Mouse (mAB) | B-cells | MS-340-S; Neomarkers, Fremont, CA, USA | 1:100; E |
CD138 | Mouse (nAB) | Plasma Cells | Serotec, MCA 681H; UK | 1:500; E |
GranB | Mouse (mAB) | Granzyme B | MS-1157-S; Neomarkers, Fremont, CA, USA | 1:1000; E |
IgG | Rabbit (pAB) | Imunoglobulin G | A0423, DAKO, Glostrup, DK | 1:400; Prot. |
IgA | Rabbit (pAB) | Immunoglobulin A | A042, DAKO, Glostrup, DK | 1:2000; Prot. |
IgM | Rabbit (pAB) | Immunoglobulin M | A426; DAKO, Glostrup, DK | 1:400; Prot |
C9neo | Rabbit (pAB) | Compement C9neo antigen | P. Morgan; Cardiff, UK | 1:2000; Prot |
PCNA | Mouse (mAB) | Proliferating cell nuclear antigen | M0879, DAKO, Glostrup, DK | 1:10000; C |
E06 | Mouse (mAB) | Oxidized phospholipids | Avantilipids; 330001S, Alabaster, AL, USA | 10μg/ml; none |
α-Syn | Mouse (mAB) | α-Synuclein | Aj.ROBOSCREEN, mab 5G4 | 1:1000; C |
AT8 | Mouse (mAB) | Phosphorylated tau-protein (PHF) | Immunogenetics, Ghent, Belgium | 1:2000; C |
AIF | Rabbit (pAB) | Apoptosis inducing factor | Milipore, AB16501; Temecula, CA | 1:250; C |
Results
Basic pathology of human autoimmune encephalitis (HAE)
Inflammatory reaction
Leukocyte | Percentage of Total Cells / Cuff |
---|---|
CD3 | 21 |
CD4 | <0.1 |
CD8 | 20 |
CD20 | 72 |
CD138 | 9 |
IgM | 7 |
IgG | 2 |
IgA | 0.7 |
% proliferating CD8+ cells | 2.3 |
% proliferating CD20+ cells | 3.5 |
Oxidative injury in neurons and glia
Pathological changes in the substantia nigra
Comparison of HAE with MS and EAE in rodents and primates
MS Pathology | AcuteMS | Progr. MS | Case HAE | Marmoset MOG EAE | Mouse MOG EAE |
---|---|---|---|---|---|
Demyelination | |||||
DM Plaques | yes | yes | yes | yes | yesa
|
Perivenous / Confluent | yes | yes | yes | yes | yes |
Periventricular | yes | yes | yes | yes | no |
Slowly expanding lesions | no | yes | no | no | no |
Dawson Fingers | yes | yes | yes | yes | no |
Leukocortical Lesions | yes | yes | yes | yes | no |
Intractortical Lesions | yes | yes | yes | yes | no |
Subpial lesions | few | many | few | yes | no |
Shadow plaques | few | var | no | yes | no |
Pattern II DM | |||||
C9neo Deposition | var | few | yes | yes | no |
Ig Deposition | var | var | yes | yes | no |
Macrophage association | yes | yes | yes | yes | yes |
Pattern III DM | |||||
Pre-phagocytic Lesions | var | few | no | no | no |
Oligodendrocyte Apoptosis | var | var | no | no | no |
Concentric DM Pattern | var | rare | no | no | no |
Axonal / Neuronal Pathology | |||||
Relative axonal pres. | yes | yes | yes | yes | no |
Acute injury in act. lesions | yes | yes | yes | few | yes |
Diffuse axonal Injury | few | mod | few | few | few |
Retrograde Neurodegeneration | few | yes | few | n.d. | yes |
Astrocyte Pathology | |||||
Protoplasmic gliosis in active lesions | yes | yes | yes | mild | yes |
Creutzfeldt Peters Cells | many | few | many | no | no |
Fibrillary Gliosis in inactive lesions | yes | yes | yes | yes | yes |
Aquaporin 4 loss | Var (Pat III) | no | no | n.d. | no |
Inflammation | |||||
CD3 | many | many | many | many | many |
CD4 | few | few | single | n.d. | many |
CD8 | many | many | many | n.d. | few |
CD20 | mod | mod | massive | mod | few |
Plasma Cells | mod | mod | mod | mod | few |
Follicle like structures | var | var | yes | yes | no |
IgG PC | many | many | few | mod | n.d. |
IgA PC | few | few | few | n.d. | n.d. |
IgM PC | few | few | many | few | n.d. |
PCNA CD8 | yes | yes | yes | n.d. | n.d. |
PCNA CD20 | yes | yes | yes | n.d. | n.d. |
Microglia / Macrophages | |||||
Iba1 (active lesions) | many | many | many | many | many |
CD68 (active lesions) | many | many | many | n.d. | many |
NADPH oxidase microglia | many | many | many | n.d. | no |
Microglia nodules | many | mod | many | few | no |
Diffuse activation NAWM/GM | mod | massive | mod | no | mod |
Iron Related Pathology | |||||
Iron accumulation in NAWM/GM | Age related | Age related | Profound (age) | no | no |
Iron loss in lesions | yes | yes | yes | no | no |
Extracellular iron | yes | yes | yes | no | no |
Uptake in Macrophages / MG | yes | yes | yes | few | no |
Iron loss in PPWM | yes | yes | no | no | no |
Oxidative Injury | |||||
Ox Lipids OG and Myelin | yes | yes | few (iron) | no | no |
Ox lipids neurons | yes | yes | few (iron) | no | no |
EBV | |||||
EBER positive B-cells | no | no | no | n.d. | n.d. |